| Product Code: ETC11477934 | Publication Date: Apr 2025 | Updated Date: Sep 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Bhawna Singh | No. of Pages: 65 | No. of Figures: 34 | No. of Tables: 19 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Ireland Cancer Genome Sequencing Market Overview |
3.1 Ireland Country Macro Economic Indicators |
3.2 Ireland Cancer Genome Sequencing Market Revenues & Volume, 2021 & 2031F |
3.3 Ireland Cancer Genome Sequencing Market - Industry Life Cycle |
3.4 Ireland Cancer Genome Sequencing Market - Porter's Five Forces |
3.5 Ireland Cancer Genome Sequencing Market Revenues & Volume Share, By Sequencing Type, 2021 & 2031F |
3.6 Ireland Cancer Genome Sequencing Market Revenues & Volume Share, By Application, 2021 & 2031F |
3.7 Ireland Cancer Genome Sequencing Market Revenues & Volume Share, By End User, 2021 & 2031F |
3.8 Ireland Cancer Genome Sequencing Market Revenues & Volume Share, By Technology, 2021 & 2031F |
4 Ireland Cancer Genome Sequencing Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of cancer in Ireland |
4.2.2 Growing demand for personalized medicine and targeted therapies |
4.2.3 Advancements in genomic technology and bioinformatics capabilities |
4.3 Market Restraints |
4.3.1 High costs associated with genome sequencing procedures |
4.3.2 Limited accessibility to advanced genomic testing facilities in remote areas |
4.3.3 Stringent regulatory requirements for genomic data privacy and protection |
5 Ireland Cancer Genome Sequencing Market Trends |
6 Ireland Cancer Genome Sequencing Market, By Types |
6.1 Ireland Cancer Genome Sequencing Market, By Sequencing Type |
6.1.1 Overview and Analysis |
6.1.2 Ireland Cancer Genome Sequencing Market Revenues & Volume, By Sequencing Type, 2021 - 2031F |
6.1.3 Ireland Cancer Genome Sequencing Market Revenues & Volume, By Whole Genome Sequencing, 2021 - 2031F |
6.1.4 Ireland Cancer Genome Sequencing Market Revenues & Volume, By Targeted Sequencing, 2021 - 2031F |
6.2 Ireland Cancer Genome Sequencing Market, By Application |
6.2.1 Overview and Analysis |
6.2.2 Ireland Cancer Genome Sequencing Market Revenues & Volume, By Oncology Research, 2021 - 2031F |
6.2.3 Ireland Cancer Genome Sequencing Market Revenues & Volume, By Precision Medicine, 2021 - 2031F |
6.3 Ireland Cancer Genome Sequencing Market, By End User |
6.3.1 Overview and Analysis |
6.3.2 Ireland Cancer Genome Sequencing Market Revenues & Volume, By Research Centers, 2021 - 2031F |
6.3.3 Ireland Cancer Genome Sequencing Market Revenues & Volume, By Hospitals, 2021 - 2031F |
6.4 Ireland Cancer Genome Sequencing Market, By Technology |
6.4.1 Overview and Analysis |
6.4.2 Ireland Cancer Genome Sequencing Market Revenues & Volume, By Next-Generation Sequencing, 2021 - 2031F |
6.4.3 Ireland Cancer Genome Sequencing Market Revenues & Volume, By Sanger Sequencing, 2021 - 2031F |
7 Ireland Cancer Genome Sequencing Market Import-Export Trade Statistics |
7.1 Ireland Cancer Genome Sequencing Market Export to Major Countries |
7.2 Ireland Cancer Genome Sequencing Market Imports from Major Countries |
8 Ireland Cancer Genome Sequencing Market Key Performance Indicators |
8.1 Average turnaround time for cancer genome sequencing tests |
8.2 Adoption rate of genomic testing in cancer diagnosis and treatment |
8.3 Number of research collaborations and partnerships in genomic medicine in Ireland |
9 Ireland Cancer Genome Sequencing Market - Opportunity Assessment |
9.1 Ireland Cancer Genome Sequencing Market Opportunity Assessment, By Sequencing Type, 2021 & 2031F |
9.2 Ireland Cancer Genome Sequencing Market Opportunity Assessment, By Application, 2021 & 2031F |
9.3 Ireland Cancer Genome Sequencing Market Opportunity Assessment, By End User, 2021 & 2031F |
9.4 Ireland Cancer Genome Sequencing Market Opportunity Assessment, By Technology, 2021 & 2031F |
10 Ireland Cancer Genome Sequencing Market - Competitive Landscape |
10.1 Ireland Cancer Genome Sequencing Market Revenue Share, By Companies, 2024 |
10.2 Ireland Cancer Genome Sequencing Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here